Cancer BiologybioRxivPreprint
CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients
Carla Pereira, Daniel Ferreira, Carolina Lemos…·Carla Oliveira
This study identifies CD44v6 expression as a predictor of therapy response and poor prognosis in gastric cancer patients, showing higher expression correlates with worse outcomes and benefit from chemotherapy.
DOI 10.1101/468934